MAM
RVMD icon

Meeder Asset Management’s Revolution Medicines RVMD Stock Holding History

Meeder Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.3K Buy
106
+35
+49% +$3.53K ﹤0.01% 690
2025
Q4 		$5.66K Sell
71
-25
-26% -$1.64K ﹤0.01% 777
2025
Q3 		$4.48K Buy
96
+19
+25% +$744 ﹤0.01% 691
2025
Q2 		$2.83K Buy
+77
New +$2.96K ﹤0.01% 784
2025
Q1 		– Sell
-88
Closed -$3.85K – 1029
2024
Q4 		$3.85K Sell
88
-14
-14% -$707 ﹤0.01% 860
2024
Q3 		$4.63K Buy
102
+30
+42% +$1.31K ﹤0.01% 756
2024
Q2 		$2.79K Buy
+72
New +$2.69K ﹤0.01% 831
2020
Q4 		– Sell
-425
Closed -$14K – 2170
2020
Q3 		$14K Buy
+425
New +$11.8K ﹤0.01% 1271

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return